![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
星球健康饮食指数与高尿素血症的关联和优化
Jia-Xin Tan1, Zhen Qin2, Qing-Zhong Li3
1Department of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Frontiers in nutrition
|October 1, 2025
概括
美国的行星健康饮食指数 (PHDI-US) 与较低的超血 (HUA) 风险有关. 在PHDI-US中优化乳制品摄入量,创造PHDI-Dairy,进一步增强了这种对HUA的保护作用.
科学领域:
- 营养流行病学 营养流行病学
- 代谢疾病 代谢疾病
- 公共卫生 营养 公共卫生 营养
背景情况:
- 超血 (HUA) 是一个重要的全球代谢健康挑战.
- 美国的行星健康饮食指数 (PHDI-US),一种可持续的饮食模式,对慢性疾病管理有希望,但其对HUA的具体影响仍在调查中.
研究的目的:
- 调查PHDI-US和HUA风险之间的关联.
- 确定PHDI-US影响HUA的关键饮食成分.
- 为预防HUA开发和验证一个优化的饮食指数.
主要方法:
- 对全国代表性的NHANES数据的分析.
- 应用多变量逻辑回归和受限立方线模型.
- 机器学习来识别关键的饮食成分和构建一个优化的PHDI-乳制品指数.
- 乳制品摄入量和HUA风险的外部队列验证.
主要成果:
- 最初的PHDI-US显示了与HUA风险的负相关性,尽管不如其他已建立的指数.
- 机器学习确定乳制品是PHDI-US.US最有影响力的组成部分.
- 优化的PHDI-乳制品指数显示,与HUA风险和更高的保护效率的负相关性更强.
- 外部验证证实,较高的乳制品消费与降低HUA风险有关.
结论:
- PHDI-US与降低高利血的风险有关.
- 优化PHDI-US以强调乳制品摄入量 (PHDI-乳制品) 显著增强其对HUA的保护作用.
- "PHDI-乳制品指数"显示了作为一种有针对性的营养战略的潜力,用于管理HUA并促进公共卫生和环境可持续性.
相关概念视频
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
356
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
356
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
01:29Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
01:28Hypertension I: Introduction
743
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
743